Quantcast

Latest Bayer AG Stories

2014-07-07 08:22:14

-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival in patients with RAI-refractory differentiated thyroid cancer compared to placebo in the Phase III DECISION trial TORONTO, July 7, 2014 /CNW/ - Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally...

2014-07-01 16:27:23

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Agrochemicals Market 2014-2018http://www.reportbuyer.com/chemicals/agricultural_chemicals/global_agrochemicals_market_2012_2016.html About AgrochemicalsAgrochemicals, also known as agrichemicals, are chemicals that enhance the yield and quality of crops. Pesticides and fertilizers are the two major types of agrochemicals. Pesticides control pests that feed on crops or on the nutrients...

2014-06-27 08:24:46

TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA(®) (aflibercept) Injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of visual impairment due to diabetic macular edema (DME). The decision of the European Commission is expected in the second half of 2014. "Diabetes is a growing health concern worldwide and this milestone brings us...

2014-06-23 12:22:59

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Polyurethane Foam Market 2014-2018http://www.reportbuyer.com/chemicals/plastics/global_polyurethane_foam_market_2014_2018.html TechNavio's analysts forecast the Global Polyurethane Foam market to grow at a CAGR of 7.03 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand from Bedding & Furniture and Construction...

2014-06-23 08:27:25

LEVERKUSEN, Germany, June 23, 2014 /PRNewswire/ -- Bayer HealthCare (Bayer) and Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, have entered into a collaboration for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. "Bayer is a worldwide leader in the treatment of hemophilia A and we are highly committed to advancing innovative treatment options for...

2014-06-19 12:26:36

LONDON, June 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019...

2014-06-17 20:20:56

LONDON, June 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Specialty Chemicals Market 2014-2018http://www.reportbuyer.com/chemicals/specialty_chemicals/global_specialty_chemicals_market_2014_2018.htmlTechNavio's analysts forecast the Global Specialty Chemicals market to grow at a CAGR of 5.16 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for specialty chemicals...

2014-06-12 08:30:27

- Gadavist-enhanced breast MRI demonstrated superior sensitivity (range: 80-89%) for the presence and extent of malignant disease compared to unenhanced breast MRI (range: 37-73%) WHIPPANY, N.J., June 12, 2014 /PRNewswire/ -- Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Gadavist(® ) (gadobutrol) injection for intravenous use with MRI of the breast to assess the presence and extent of malignant breast disease. The...

2014-06-11 04:21:59

TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA(®) (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). The EMA submission is based on the positive Phase 3 VIBRANT trial, a double-masked,...

2014-06-03 08:33:28

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Equine Healthcare Market (Diagnostic Products, Therapeutic Products and Supplement Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019http://www.reportbuyer.com/pharma_healthcare/therapeutic/equine_healthcare_market_diagnostic_products_therapeutic_products_supplement_products_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html The...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related